1. Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma. (8th July 2013) Authors: Kim, M.; Li, M.; Intong, L.R.A.; Tran, K.; Melbourne, W.; Marucci, D.; Bucci, J.; de Souza, P.; Mallesara, G.; Murrell, D.F. Journal: British journal of dermatology Issue: Volume 169:Number 1(2013:Jul.) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗